Profile
Wei Dong Liu is currently a Non-Executive Director at Tot Biopharm Co. Ltd. since 2023.
Former positions include Non-Executive Director at BioDlink International Co., Ltd. from 2023 to 2026 and Non-Executive Director at Genetron Holdings Ltd. Education includes a doctorate from the University of Pittsburgh conferred in 2000, an undergraduate degree from Peking University conferred in 1989, and a graduate degree from Peking University conferred in 1994.
Wei Dong Liu active positions
| Companies | Position | Start |
|---|---|---|
Tot Biopharm Co. Ltd.
Tot Biopharm Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets oncology drugs and therapies | Director/Board Member | 2023-08-11 |
Former positions of Wei Dong Liu
| Companies | Position | End |
|---|---|---|
| BIODLINK INTERNATIONAL COMPANY LIMITED | Director/Board Member | 2026-04-28 |
| GENETRON HOLDINGS LIMITED | Director/Board Member | - |
Education of Wei Dong Liu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Pittsburgh
University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tot Biopharm Co. Ltd.
Tot Biopharm Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets oncology drugs and therapies | Health Technology |
TOT BIOPHARM International Co. Ltd.
TOT BIOPHARM International Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets anti-tumor drugs | Health Technology |
Genetron Holdings Ltd.
Genetron Holdings Ltd. Medical/Nursing ServicesHealth Services Provides molecular profiling and diagnostics services | Health Services |
- Stock Market
- Insiders
- Wei Dong Liu
















